Com-COV vaccine study to research third dose booster options

The Com-COV 3 study has been commissioned through the NIHR and backed by £2.8 million government funding, with support from both the Vaccine Taskforce and National Institute for Health and Care Research (NIHR). This new stage of the study – which wil

Related Keywords

United Kingdom , Jakob Cramer , Stanleyc Erck , Matthew Snape , Andrew Ustianowski , University Of Oxford , Committee On Vaccination , Care Research Wales , Regulatory Agency , Coalition For Epidemic Preparedness Innovations , Pfizer , National Institute For Health , National Infection Specialty , National Immunisation Schedule Evaluation Consortium , Vaccination Programme , Care Research , Clinical Development , Vaccine Taskforce , National Institute , Epidemic Preparedness Innovations , Chief Investigator , Joint National Infection Specialty Lead , Chief Executive Officer , Joint Committee ,